Skip to main content
BrainCited

Phosphatidylserine Attention & Focus Difficulties

C

Research suggests phosphatidylserine may help support focus and reduce behaviors associated with attention difficulties, particularly in stressed individuals.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dphosphatidylserine\u0026condition\u003Dattention\u002Dfocus'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

Research suggests phosphatidylserine may help support focus and reduce behaviors associated with attention difficulties, particularly in stressed individuals.

Key Study Findings

Other
Functional food lycopene mitigates obesity-related cognitive decline via lipid metabolism regulation and neuroprotection via taurine …
Dose: 50 mg/kg lycopene in mice vs: HFD control mice Outcome: Cognitive function (Y-maze, MWM, novel object recognition) 効果: None None

対象集団: HFD-induced obese male C57BL/6 mice

In Vitro
The uremic solute 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) may enhance eryptosis and increase erythrocyte osmotic fragility through potential …
Dose: None vs: None Outcome: CMPF-induced eryptosis via PIEZO1 activation 効果: None None

対象集団: Human red blood cells from healthy individuals

Other
Initiation of Progressive Morphological Transition Towards an Echino-Stomato-Spherocytic Phenotype by Phosphatidylserine Externalization and Its Implication …
Dose: None vs: Untreated erythrocytes Outcome: Erythrocyte morphological transition and thrombosis 効果: None None

対象集団: Rat erythrocytes (in vitro/in vivo)

Other
Milk Fat Globules: 2024 Updates.
Dose: None vs: None Outcome: Inflammatory markers 効果: None None

対象集団: None

Randomized Controlled Trial n=138 6.0 weeks Double-blind
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study Investigating the Efficacy of a Whole Coffee Cherry Extract …
Dose: None vs: placebo Outcome: cognitive function 効果: None p ≤ 0.024

対象集団: Adults with cognitive concerns

In Vitro
Concentration of Phosphatidylserine Influence Rates of Insulin Aggregation and Toxicity of Amyloid Aggregates In Vitro.
Dose: 40% vs: None Outcome: lipid levels 効果: None None

対象集団: None

Key Statistics

5

研究数

350

参加者数

Positive

C

グレード

Referenced Papers

Newborn (Clarksville, Md.) 2024 9 件の引用
Wiener medizinische Wochenschrift … 2023 4 件の引用
The Senior care … 2021 2 件の引用
Cellular physiology and … 2017 17 件の引用
Cellular physiology and … 2016 50 件の引用
Journal of analytical … 2016 49 件の引用
Nutrition (Burbank, Los … 2015 149 件の引用
European journal of … 2015 28 件の引用
Basic & clinical … 2015 17 件の引用
Journal of molecular … 2014 138 件の引用
Molecular biology of … 2012 173 件の引用
Journal of agricultural … 2012 33 件の引用
Archives of biochemistry … 2011 20 件の引用
American journal of … 2011 17 件の引用
Thrombosis research 2010 155 件の引用
Cellular physiology and … 2010 51 件の引用
Biological research for … 2010 49 件の引用
Archives of toxicology 2009 78 件の引用
Kidney & blood … 2008 62 件の引用
Cellular physiology and … 2008 46 件の引用
FASEB journal : … 2006 244 件の引用
Naunyn-Schmiedeberg's archives of … 2006 63 件の引用
Cellular and molecular … 2005 747 件の引用
Advances in experimental … 2004 29 件の引用
Neurochemical research 2003 82 件の引用
Current opinion in … 2000 256 件の引用
Biochimica et biophysica … 1995 7 件の引用
Biochimica et biophysica … 1980 118 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
100 mg/day
cognitivesupport:
100-300 mg/day

上限量: Well-tolerated up to 600 mg/day

研究で検討された用量

用量 期間 効果 N
50 mg/kg lycopene in mice -- Positive --
None -- Negative --
None -- Negative --
None -- Positive --
None 6.0 weeks Mixed 138
40% -- Mixed --
None -- Mixed --
4 g -- Mixed --

推奨摂取タイミング: With meals for better absorption

Safety & Side Effects

報告されている副作用

  • Mild gastrointestinal discomfort
  • Insomnia at high doses
  • Rare allergic reactions (soy-derived forms)

既知の相互作用

  • Anticholinergic medications (may reduce PS effectiveness)
  • Blood thinners (theoretical interaction)
  • Cholinesterase inhibitors (additive cholinergic effects)

耐容上限摂取量: Well-tolerated up to 600 mg/day

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Phosphatidylserine help with Attention & Focus Difficulties?
Based on 5 studies with 350 participants, there is limited but promising evidence that Phosphatidylserine may support Attention & Focus Difficulties management. Our evidence grade is C (Some Evidence).
How much Phosphatidylserine should I take for Attention & Focus Difficulties?
Studies have used various dosages. A commonly studied range is 100 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Phosphatidylserine?
Reported side effects may include Mild gastrointestinal discomfort, Insomnia at high doses, Rare allergic reactions (soy-derived forms). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Phosphatidylserine and Attention & Focus Difficulties?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分: Attention & Focus Difficulties

Phosphatidylserine 他の症状・状態について

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。